Rani Therapeutics Holdings RANI Balance Sheet (2020-2026)

NASDAQ RANI
$0.84 +0.02 (+2.51%)
At close: Sep 11, 2026 · 4:00 PM EDT
Reported Financials

Rani Therapeutics Holdings Quarterly Balance Sheet

Periods 25 quarters
Latest Jun 2026

Rani Therapeutics Holdings reported total assets of $60.84M and total liabilities of $12.86M for the quarter ended Jun 2026, up 260.1% year over year. This balance sheet covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Receivables - AccuredAcc. Int. Receivables
0.20M0.10M0.20M0.20M0.20M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
129.74M117.45M107.84M97.18M27.22M27.01M18.98M7.55M4.97M5.86M6.88M4.51M4.28M3.76M10.11M10.22M4.14M18.62M43.40M53.40M
Receivables - NetNet Receivables
0.40M0.60M2.04M2.04M2.04M
Receivables - OtherOther Receivables
0.43M
Receivables
0.83M0.60M2.04M2.04M2.04M
Prepaid Assets
2.62M2.14M1.42M0.81M2.55M2.44M1.75M1.77M2.70M2.31M1.81M1.13M1.97M1.68M1.33M0.86M0.81M1.57M1.65M1.09M
Current Assets
132.37M119.59M109.26M97.99M100.72M100.92M89.04M76.37M63.22M50.85M41.39M32.03M32.37M29.74M17.78M11.07M4.96M53.32M47.09M56.52M
Non-Current Assets
Construction in Progress
3.50M
Property, Plant & Equipment (Net)
4.59M4.61M4.89M5.35M5.68M6.04M5.99M5.94M6.25M6.11M5.91M5.70M5.50M1.55M1.35M1.14M0.92M0.74M0.60M0.53M
Long-Term Deferred Tax
17.40M18.30M18.00M18.70M18.70M18.80M18.90M18.90M18.90M
Other Non-Current Assets
0.50M0.25M0.25M0.25M0.25M0.25M0.25M0.29M0.24M0.25M0.25M0.25M
Non-Current Assets
4.59M4.61M6.05M6.35M7.48M7.10M7.41M7.13M7.21M7.07M12.12M11.69M11.17M6.89M6.34M5.83M5.18M5.30M4.79M4.32M
Assets
136.96M124.21M115.31M104.34M108.20M108.03M96.45M83.51M70.44M57.92M53.51M43.73M43.54M36.63M24.12M16.90M10.14M58.62M51.88M60.84M
Liabilities
Current Liabilities
Accounts Payables
1.31M1.08M1.26M1.44M1.79M1.46M1.51M1.04M1.41M0.65M0.81M0.51M1.57M1.36M1.52M1.80M2.47M0.31M0.86M1.05M
Notes Payables
0.29M0.13M0.14M0.03M0.06M0.05M
Payables
1.60M1.21M1.41M1.47M1.84M1.51M1.51M1.04M1.41M0.65M0.81M0.51M1.57M1.36M1.52M1.80M2.47M0.31M0.86M1.05M
Accumulated Expenses
3.65M1.43M2.10M3.22M4.36M2.35M2.72M3.84M3.93M1.73M2.76M2.42M1.87M2.07M2.29M2.64M2.09M3.94M4.71M3.14M
Short term Debt
1.22M4.90M8.59M12.29M14.77M15.00M15.00M15.00M13.54M
Current Leases
0.65M0.66M0.98M1.01M0.92M0.86M0.79M0.72M1.22M1.36M1.41M1.46M1.32M1.19M1.05M1.59M1.46M1.33M
Current Deferred Revenue
0.60M8.54M6.83M5.12M
Total Current Liabilities
5.25M2.64M4.16M5.35M7.19M4.82M5.15M5.74M7.34M7.99M13.38M16.58M20.21M19.89M20.13M20.62M19.14M12.67M13.86M10.64M
Non-Current Liabilities
Non-Current Debt
14.09M29.15M29.21M29.27M28.10M24.48M20.85M17.21M13.54M9.61M5.92M2.23M
Non-Current Deffered Revenue
1.71M
Preferred Stock Liabilities
Minority Interest
80.34M74.16M57.26M50.84M44.41M37.15M30.87M24.07M17.27M12.58M7.14M2.71M2.65M1.50M-2.29M-3.58M-4.11M8.50M7.14M8.75M
Operating Leases
0.51M0.34M0.32M0.06M0.50M0.34M0.17M4.75M4.39M4.02M3.64M3.42M3.20M2.97M2.73M2.48M2.22M
Other Non-Current Liabilities
Total Non-Current Liabilities
5.25M2.64M
Total Liabilities
5.25M2.64M4.67M5.69M21.59M34.02M34.86M35.34M35.62M32.47M38.98M38.18M37.77M33.14M29.47M26.05M22.11M17.11M16.34M12.86M
Shareholder's Equity
Total Debt
0.29M0.13M0.14M0.03M14.15M29.20M29.21M29.27M29.32M29.38M29.44M29.50M28.30M24.61M20.92M17.23M13.54M
Common Equity
131.71M121.57M110.64M98.65M86.61M74.00M61.59M48.17M34.82M25.44M14.54M5.55M5.78M3.49M-5.35M-9.15M-11.97M41.51M35.54M47.98M
Liabilities and Shareholders Equity
136.96M124.21M115.31M104.34M108.20M108.03M96.45M83.51M70.44M57.92M53.51M43.73M43.54M36.63M24.12M16.90M10.14M58.62M51.88M60.84M
Retained Earnings
54.50M55.74M67.93M69.99M72.38M75.84M78.02M80.75M83.38M85.76M87.78M90.01M97.07M104.89M-110.20M-116.90M-122.30M165.58M168.01M186.25M
Preferred Shares
Treasury Shares